Prevalence and clinical impact of VIral Respiratory tract infections in patients hospitalized for Community-Acquired Pneumonia: the VIRCAP study
- 24 Downloads
Prevalence and clinical impact of viral respiratory tract infections (VRTIs) on community-acquired pneumonia (CAP) has not been well defined so far. The aims of this study were to investigate the prevalence and the clinical impact of VRTIs in patients with CAP. Prospective study involving adult patients consecutively admitted at medical wards for CAP and tested for VRTIs by real-time PCR on pharyngeal swab. Patients’ features were evaluated with regard to the presence of VRTI and aetiology of CAP. Clinical failure was a composite endpoint defined by worsening of signs and symptoms requiring escalation of antibiotic treatment or ICU admission or death within 30 days. 91 patients were enrolled, mean age 65.7 ± 10.6 years, 50.5% female. 62 patients (68.2%) had no viral co-infection while in 29 patients (31.8%) a VRTI was detected; influenza virus was the most frequently identified (41.9%). The two groups were similar in terms of baseline features. In presence of a VRTI, pneumonia severity index (PSI) was more frequently higher than 91 and patients had received less frequently pre-admission antibiotic therapy (adjusted OR 2.689, 95% CI 1.017–7.111, p = 0.046; adjusted OR 0.143, 95% CI 0.030–0.670, p = 0.014). Clinical failure and antibiotic therapy duration were similar with regards to the presence of VRTI and the aetiology of CAP. VRTIs can be detected in almost a third of adults with CAP; influenza virus is the most relevant one. VRTI was associated with higher PSI at admission, but it does not affect patients’ outcome.
KeywordsViral respiratory tract infections Community-acquired pneumonia Influenza Pneumonia severity index
The authors declare no funding foundation.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Regional Ethics Committee (Regional Ethics Committee of Liguria Region, Registry Number 357RE62016).
Participants signed specific informed consent.
- 5.Arnold FW, Wiemken TL, Peyrani P et al (2013) Mortality differences among hospitalized patients with community-acquired pneumonia in three world regions: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med 107:1101–1111. https://doi.org/10.1016/j.rmed.2013.04.003 CrossRefPubMedGoogle Scholar
- 8.Nicholson KG, Kent J, Hammersley V, Cancio E (1997) Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ 315:1060–1064. https://doi.org/10.1136/bmj.315.7115.1060 CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Couch RB, Englund JA, Whimbey E (1997) Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 102:2–9. 10.1016/s0002–9343(97)00003-x (discussion 25–26)Google Scholar
- 13.Templeton KE, Scheltinga SA, Beersma MFC et al (2004) Rapid and sensitive method using multiplex real-time PCR for diagnosis of infections by influenza a and influenza B viruses, respiratory syncytial virus, and parainfluenza viruses 1, 2, 3, and 4. J Clin Microbiol 42:1564–1569. https://doi.org/10.1128/jcm.42.4.1564-1569.2004 CrossRefPubMedPubMedCentralGoogle Scholar
- 14.van Elden LJR, van Kraaij MGJ, Nijhuis M et al (2002) Polymerase chain reaction is more sensitive than viral culture and antigen testing for the detection of respiratory viruses in adults with hematological cancer and pneumonia. Clin Infect Dis 34:177–183. https://doi.org/10.1086/338238 CrossRefPubMedGoogle Scholar
- 23.Peltola VT, McCullers JA (2004) Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J 23:S87–97. https://doi.org/10.1097/01.inf.0000108197.81270.35 CrossRefPubMedGoogle Scholar
- 28.Uyeki TM, Bernstein HH, Bradley JS et al (2019) Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa. Clin Infect Dis 68:e1–e47. https://doi.org/10.1093/cid/ciy866 CrossRefPubMedPubMedCentralGoogle Scholar
- 38.Smith CM, Sandrini S, Datta S et al (2014) Respiratory syncytial virus increases the virulence of Streptococcus pneumoniae by binding to penicillin binding protein 1a. A new paradigm in respiratory infection. Am J Respir Crit Care Med 190:196–207. https://doi.org/10.1164/rccm.201311-2110OC CrossRefPubMedPubMedCentralGoogle Scholar
- 41.Cunha CB (2016) Relation of diagnostic accuracy of viral respiratory polymerase chain reaction to specimen number and source in severe adenovirus pneumonia: antimicrobial stewardship implications. Infect Control Hosp Epidemiol 37:1127–1129. https://doi.org/10.1017/ice.2016.144 CrossRefPubMedGoogle Scholar